Human Caring Theory-Based Yoga and Anxiety

NCT07797595 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-09-01

No results posted yet for this study

Summary

This controlled interventional study aims to evaluate the effect of a Human Caring Theory-based yoga program on state anxiety levels in adolescents diagnosed with cancer. Adolescents aged 12-18 years who are receiving outpatient follow-up will be assigned to an intervention group or a control group. The intervention group will participate in an individualized four-week online yoga program delivered through Zoom, comprising two 60-minute sessions per week. The control group will receive no study intervention and will complete the same data collection forms. State anxiety will be assessed using the State Anxiety Inventory (STAI-I). The study will be conducted through the Pediatric Oncology Outpatient Clinic of Akdeniz University Hospital in Antalya, Türkiye.

Conditions

Interventions

BEHAVIORAL

Human Caring Theory-Based Individualized Online Yoga Program

The theory-based program incorporates yoga postures, breathing practices, relaxation, mindfulness, and mind-body awareness. Before each session, the adolescent's physical capacity and limitations will be assessed, and the postures will be adapted accordingly. Sessions will be delivered individually by a pediatric oncology researcher who is also a trained children's yoga instructor.

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2027-07-20
Completion
2027-08-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07797595 on ClinicalTrials.gov